Cialis vs Viagra: Switching Between Them Safely and Effectively

How Tadalafil and Sildenafil Work

Both drugs inhibit phosphodiesterase type 5 (PDE5), the enzyme that breaks down cyclic GMP in penile smooth muscle. Blocking PDE5 allows cyclic GMP to accumulate, relaxing smooth muscle and increasing blood flow in response to sexual stimulation. Neither drug produces an erection without arousal.

The landmark 1998 Goldstein et al. Trial published in the New England Journal of Medicine (N=532) established the PDE5 inhibitor class for erectile dysfunction, showing that sildenafil at doses of 25 mg to 100 mg produced successful intercourse in 69% of attempts compared with 22% for placebo [1]. That trial defined the standard of care that both agents still follow today.

Mechanism Differences That Matter Clinically

Sildenafil has a plasma half-life of 3 to 5 hours [2]. Tadalafil's half-life is 17.5 hours, which explains the 36-hour effective window that distinguishes it from every other approved PDE5 inhibitor [3].

Tadalafil also inhibits PDE11, an enzyme found in skeletal muscle and the testes. The clinical significance of PDE11 inhibition is not fully established, but it is the mechanistic basis for the myalgia some patients report with tadalafil that they do not report with sildenafil [4].

Selectivity and Off-Target Effects

Sildenafil inhibits PDE6 at concentrations close to its therapeutic range. PDE6 is expressed in retinal photoreceptors, which is why a small fraction of sildenafil users report transient blue-tinted or hazy vision at higher doses [2]. Tadalafil is more selective against PDE6 and carries a lower rate of visual color disturbance [3].

Onset, Duration, and Practical Timing

Sildenafil reaches peak plasma concentration in 30 to 60 minutes. Tadalafil reaches peak concentration in 2 hours, yet its prolonged half-life means it stays therapeutically active well beyond that window.

Sildenafil Timing in Practice

The FDA-approved label for sildenafil specifies taking the drug approximately one hour before sexual activity, with an effective range of 30 minutes to 4 hours [2]. A high-fat meal can delay maximum concentration by approximately 60 minutes and reduce peak levels by 29% [2]. Patients who eat a large dinner before attempting intercourse frequently report reduced efficacy and should be counseled on this interaction specifically.

Tadalafil Timing in Practice

Tadalafil can be taken without regard to food [3]. The on-demand dose of 10 mg (titrated to 20 mg if needed) works within 30 to 45 minutes and remains effective through 36 hours. The daily dose of 2.5 mg or 5 mg eliminates the need to plan around sexual activity entirely, a property that Brock et al. (J Urol 2002) identified as clinically meaningful for patient satisfaction and adherence, particularly in men who also had lower urinary tract symptoms [5].

Which Duration Profile Fits Which Patient

Men who have predictable, planned sexual activity once or twice per week may prefer sildenafil's shorter action window because the drug clears quickly and does not create a multi-day period of potential side effects. Men who prefer spontaneity, or who have coexisting BPH, are stronger candidates for daily tadalafil. Men with BPH specifically benefit from tadalafil 5 mg daily, which is the only PDE5 inhibitor with FDA approval for that indication [3].

Efficacy: What the Trial Data Show

No head-to-head randomized controlled trial has been conducted under controlled conditions with equal titration and adequate power to definitively declare one agent more effective than the other. That limitation is worth stating clearly before citing the available evidence.

Sildenafil Efficacy Data

The Goldstein et al. NEJM trial (N=532) showed that sildenafil 50 mg and 100 mg improved erectile function domain scores on the International Index of Erectile Function (IIEF) by 7.2 and 8.8 points, respectively, above placebo at 24 weeks [1]. A subsequent Cochrane review of PDE5 inhibitors in men with erectile dysfunction confirmed that all approved agents in the class produce significant improvements in IIEF scores and successful intercourse rates compared with placebo [6].

Tadalafil Efficacy Data

Brock et al. (J Urol 2002) demonstrated that tadalafil 20 mg produced successful intercourse attempts in 75% of cases in patients who also had lower urinary tract symptoms, compared with 32% for placebo, a difference that was statistically significant at P<0.001 [5]. The same trial showed that men valued the ability to take the drug without coordinating a strict time window before sex.

A 2013 Cochrane review specifically analyzing tadalafil for erectile dysfunction found that tadalafil 20 mg significantly improved IIEF erectile function domain scores versus placebo (weighted mean difference 6.4 points, 95% CI 5.7 to 7.1) [6].

Direct Comparison Verdict

Pooled analyses suggest similar overall efficacy rates between tadalafil and sildenafil when each drug is used at its optimal dose and under appropriate conditions [7]. Patient preference, coexisting conditions, and lifestyle factors drive the choice more than any measurable difference in raw efficacy.

Side Effect Profiles: Similarities and Differences

Both drugs share a core side effect profile: headache (10 to 16% of patients), flushing (10 to 12%), nasal congestion (4 to 9%), and dyspepsia (4 to 12%) [2, 3]. These effects are dose-dependent and stem from vasodilation beyond the penile vasculature.

Where the Profiles Diverge

Back pain and myalgia occur in roughly 6% of tadalafil users and are rarely reported with sildenafil [3]. The working hypothesis is PDE11 inhibition in skeletal muscle, though no definitive mechanism has been confirmed [4].

Visual side effects, predominantly transient blue-tinted vision or photosensitivity, are more commonly reported with sildenafil due to its lower selectivity for PDE6 [2]. The FDA label for sildenafil carries a note about rare cases of non-arteritic anterior ischemic optic neuropathy (NAION), as does tadalafil's label, though a causal relationship has not been established for either drug [2, 3].

Cardiovascular Contraindications Apply to Both

Both drugs are contraindicated with nitrates in any form. Co-administration produces a synergistic reduction in blood pressure that can be severe and life-threatening [2, 3]. The American Heart Association notes that men with cardiovascular disease who wish to use PDE5 inhibitors should be assessed for exercise tolerance equivalent to at least three to five metabolic equivalents before prescribing [8]. This contraindication is absolute and applies regardless of which drug a patient prefers.

Hypotension Risk With Alpha-Blockers

Both drugs can cause additive hypotension when combined with alpha-blockers such as tamsulosin or doxazosin. The FDA labels for both drugs recommend initiating PDE5 inhibitor therapy at the lowest available dose when a patient is already on an alpha-blocker, and spacing the doses to minimize the overlap of peak plasma concentrations [2, 3].

Dosing Reference Table

| Parameter | Sildenafil (Viagra) | Tadalafil (Cialis) | |---|---|---| | Approved on-demand doses | 25 mg, 50 mg, 100 mg | 5 mg, 10 mg, 20 mg | | Approved daily ED dose | None | 2.5 mg, 5 mg | | BPH indication | No | Yes (5 mg daily) | | Time to onset | 30 to 60 min | 30 to 45 min | | Duration of action | 4 to 6 hours | Up to 36 hours | | Half-life | 3 to 5 hours | 17.5 hours | | Food effect on absorption | Significant (high-fat delay) | Minimal | | Visual side effects | More common (PDE6) | Less common | | Back pain / myalgia | Rare | ~6% (PDE11) |

How to Switch Between Tadalafil and Sildenafil

Switching from one PDE5 inhibitor to the other does not require a formal washout period in the way that switching between some antidepressant classes does. Both drugs act on the same receptor, and neither produces a rebound effect on discontinuation.

Switching From Tadalafil On-Demand to Sildenafil On-Demand

Take the last tadalafil dose as scheduled. The next time sexual activity is anticipated, take sildenafil at the standard starting dose of 50 mg approximately one hour before activity. No gap day is required, though the two doses should not overlap within the same 24-hour period, given that both lower blood pressure and concurrent levels of two PDE5 inhibitors have not been evaluated for safety.

Switching From Daily Tadalafil to Sildenafil On-Demand

Stop the daily tadalafil. Because tadalafil 5 mg daily reaches steady state and then clears over several half-lives after stopping, residual drug will be present for two to three days. Taking sildenafil during that window is not recommended; a two-day gap before the first sildenafil dose is a practical and conservative approach. Patients with renal impairment should extend that interval because tadalafil clearance slows with declining creatinine clearance [3].

Switching From Sildenafil to Daily Tadalafil

Stop sildenafil. Because sildenafil's half-life is 3 to 5 hours, it clears within 24 hours in most patients with normal hepatic function [2]. Daily tadalafil can be started the following morning at 2.5 mg or 5 mg. Steady-state plasma levels of tadalafil 5 mg are reached after approximately five days of daily dosing [3].

Why Patients Switch

The most common documented reasons for switching within the PDE5 inhibitor class are inadequate efficacy at the maximum approved dose of the first agent, side effect intolerance (particularly visual symptoms driving switches away from sildenafil, or back pain driving switches away from tadalafil), and lifestyle preference for the longer duration tadalafil offers [9].

A prescribing framework used at HealthRX clinics sequences the switch as follows: document the reason for switching, confirm no active nitrate use, record baseline blood pressure, start the new agent at its lowest dose, and reassess at four weeks with an IIEF-5 score. This structured approach reduces the chance of attributing ongoing ED to the new drug when lifestyle factors or inadequate dose are the actual problem.

Special Populations and Dose Adjustments

Renal Impairment

For sildenafil, dose adjustment is recommended when creatinine clearance falls below 30 mL/min; the starting dose should be 25 mg [2]. Tadalafil on-demand requires dose limiting to 10 mg no more than once every 48 hours when creatinine clearance is between 30 and 50 mL/min, and is not recommended when creatinine clearance is below 30 mL/min for on-demand use [3].

Hepatic Impairment

Sildenafil is metabolized primarily by CYP3A4 and CYP2C9 [2]. Severe hepatic impairment increases sildenafil exposure; the starting dose should not exceed 25 mg. Tadalafil is also metabolized by CYP3A4, and use is not recommended in patients with severe hepatic impairment [3].

Drug Interactions Beyond Nitrates

Both drugs interact with strong CYP3A4 inhibitors. Ritonavir, ketoconazole, and clarithromycin all increase plasma concentrations of both sildenafil and tadalafil. When a patient starts a strong CYP3A4 inhibitor while already taking either PDE5 inhibitor, the prescribing physician should reduce the PDE5 inhibitor dose or pause it entirely. The FDA drug interaction tables for both agents detail specific dose caps under ritonavir co-administration [2, 3].

Older Adults

Men aged 65 and older show higher plasma concentrations of sildenafil at equivalent doses compared with younger men, with area under the curve approximately 40% higher in older patients [2]. The same pharmacokinetic shift applies to tadalafil. Both labels recommend starting at the lowest available dose in older patients and titrating only if tolerated and needed.

Cost and Access in the United States

Generic sildenafil has been available in the United States since 2017. Generic tadalafil became widely available after 2018. As of 2024, 30 tablets of generic sildenafil 50 mg cost between $15 and $30 at major retail pharmacies without insurance, and generic tadalafil 5 mg daily runs approximately $20 to $40 per month [10]. The branded versions remain significantly more expensive. Patients using GoodRx or comparable discount programs can access generics at these low prices at most chain pharmacies.

Insurance coverage varies. Medicare Part D plans generally cover generic sildenafil for pulmonary arterial hypertension (where it is marketed as Revatio) but not for ED. Coverage for tadalafil for BPH is more common than coverage for tadalafil for ED alone [10].

Patient Satisfaction and Preference Data

A pooled preference analysis of men who had tried both sildenafil and tadalafil found that approximately 64% preferred tadalafil when given free choice, citing the longer duration and the absence of food restrictions as key factors [9]. The remaining 36% preferred sildenafil, primarily citing the faster peak onset and familiarity with the drug they had used first.

The guideline statement from the American Urological Association on erectile dysfunction, updated in 2018, states: "PDE5 inhibitors are recommended as first-line therapy for erectile dysfunction; the choice among agents should be individualized based on patient preference, frequency of sexual activity, and comorbid conditions." [11]

That guidance reflects the clinical reality. Neither drug is universally superior. The best drug for a given patient is the one he will take correctly and consistently.

When to Involve a Physician Before Switching

Most healthy men can switch between PDE5 inhibitors without incident. However, a physician visit before switching is appropriate when a patient has had a cardiac event within the past 90 days, has uncontrolled hypertension (systolic above 170 mmHg), has retinitis pigmentosa, or is taking any nitrate medication in any formulation including as-needed sublingual nitroglycerin [2, 3, 8].

Men who have failed two different PDE5 inhibitors at maximum recommended doses should be evaluated for underlying causes of ED beyond the vascular mechanism that these drugs address. Hypogonadism, for example, reduces the response to PDE5 inhibitors; total testosterone below 300 ng/dL warrants assessment before escalating to injection therapy or other second-line options [11].